Moriya Tsuji,Guangwu Chen,Richard W. Franck,Guangli Yang
申请号：
US12302011
公开号：
US08883745B2
申请日:
2007.05.22
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention is directed to novel synthetic C-glycolipids that selectively induce a ThI-type immune response characterized by enhanced IL-12 secretion and increased activation of dendritic cells. The compounds of the invention are thereby useful in treating infections, cancers, cell proliferative disorders, and autoimmune diseases, both directly and as adjuvants.
